Kaspien Holdings Inc.
Kaspien Holdings Inc. (KSPN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
kspn · pe ratio · data through Jan 28, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Kaspien Holdings Inc. (KSPN) measures how much investors pay for each dollar of the company's trailing earnings. KSPN's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$5.47.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-01-28
PE Ratio History
2004 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 10 fiscal years · Front-end computedMinQ1 · 25%49.4x
MedianQ3 · 75%526.9x
Max
At N/A, KSPN's current P/E is lower than in 0% of its annual fiscal year readings over the past 10 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Software - Application · 5 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Kaspien Holdings Inc.You KSPN | $0M | N/A | — | -$5.47 |
 Comera Life Sciences Holdings, Inc. CMRA | $0M | N/A | — | -$1.72 |
 Intelligent Living Application Group Inc. ILAG | $8M | N/A | — | -$9.50 |
 Quoin Pharmaceuticals, Ltd. QNRX | $3M | N/A | — | -$10.55 |
 Revelation Biosciences, Inc. REVB | $4M | N/A | — | -$14.36 |
 Virax Biolabs Group Limited VRAX | $1M | N/A | — | -$1.96 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-01-28Latest FY2023 | — | $-5.47 | — | |
2022-01-29 FY2022 | — | $-3.28 | — | |
2021-01-30 FY2021 | — | $-2.10 | — | |
2020-02-01 FY2020 | — | $-32.35 | — | |
2019-02-02 FY2019 | — | $-53.43 | — | |
2018-02-03 FY2018 | — | $-23.60 | — | |
2017-01-28 FY2017 | 67.56x | $1.72 | -11.1% | |
2016-01-30 FY2016 | 76.03x | $1.73 | -38.6% | |
2015-01-31 FY2015 | 123.91x | $1.12 | +297.4% | |
2014-02-01 FY2014 | 31.18x | $5.08 | +378.6% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Kaspien Holdings Inc. (KSPN) measures how much investors pay for each dollar of the company's trailing earnings. KSPN's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$5.47.
Frequently asked questions
KSPN pe ratio · 6 questionsKSPN's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$5.47. Data sourced from Financial Modeling Prep via KSPN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Kaspien Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09